The diagnosis of major depressive disorder is based on the patient's self-reported experiences, behavior reported by relatives or friends, and a mental status examination. There is no laboratory ...

Cite this: Duloxetine in the Treatment of Major Depressive Disorder: An Open-Label Study - Medscape - Aug 28, 2007.

MDD = major depressive disorder, GAD = generalized anxiety disorder ... symptom-based diagnosis system through revealing latent factors that indicate hidden causes of mental disorders and potentially ...

Introduction: Major depressive disorder (MDD) is a debilitating disease involving sensory and higher-order cognitive dysfunction. Previous work has shown altered asymmetry in MDD, including abnormal ...

Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.

Johnson & Johnson said on Thursday it will discontinue a late-stage study of its add-on treatment for major depressive ...

Depression and anxiety affect approximately 40% of adults with chronic pain, according to a massive new systematic review and meta-analysis published in JAMA Network Open. The comprehensive study ...

(Reuters) -Johnson & Johnson will stop late-stage studies of its experimental drug to treat major depressive disorder due to ...

Treatment-resistant depression (TRD) occurs when major depressive disorder (MDD) treatment does not work. There is no official definition or set criteria for TRD, but the measure often used is an ...

Objective This study aimed to investigate the incidence of overweight in patients with major depressive disorder (MDD) ...